InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Explore the detailed record of transactions filed by Myszkowski Kenneth Allen, Chief Financial Officer. Insider active across 1 companies, notably Arrowhead Pharmaceuticals, INC.. In total, 4 reports have been recorded. Total volume traded: €1.7m. The latest transaction was filed on 5 January 2022 (Cession). Regulator: SEC (Form 4). All data is openly available.
Declarations4 total
€852,94715,908 shares@ €53.61750.0079% mcap100.0% of flow
Common Stock
SEC:0001209191-22-002290·
€852,94715,908 shares@ €53.61750.0079% mcap50.0% of flow
Common Stock
SEC:0001209191-22-002290:0·
060,000 shares0
Common Stock
SEC:0001209191-22-001299·
060,000 shares0
Common Stock
SEC:0001209191-22-001299:0·
4 of 4 declarations
About Myszkowski Kenneth Allen
Kenneth Allen Myszkowski is Chief Financial Officer at Arrowhead Pharmaceuticals, Inc. He manages the company's finances, overseeing financial reporting and budgeting strategy. His role is crucial for ensuring financial transparency and regulatory compliance at Arrowhead Pharmaceuticals.
